Single-use Bioprocessing Market

Single-use Bioprocessing Market Size (2022 to 2027)

The size of the global single-use bioprocessing market is estimated to be worth USD 8.79 billion by 2027 and USD 3.92 billion in 2022, growing at a CAGR of 17.5% from 2022 to 2027. 

Single-use bioprocessing technology is majorly utilized in the manufacturing of biopharmaceuticals. The technique is used throughout the complete biopharmaceutical production process, from buffer and media preparation to biologics shipping. Single-use bioprocessing techniques are carried out through different products. Leading products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, and single-use mixers. These items lower the cost of complex bioproduction procedures, such as cleaning, sterilization, and care of the big bioreactors.

MARKET DRIVERS:

Y-O-Y growth in biopharmaceuticals and increasing R&D activities by the pharmaceutical companies are expected to accelerate the global single-use bioprocessing market growth.

According to BioPharm International, around 85% of the pre-commercial biomanufacturing includes single-use bioprocessing infrastructure. With the rising demand for pharmaceutical products worldwide, many advanced technologies comprise automation, big data, and machine learning. The increasing importance for single-use products reproduced, the establishment of ongoing biomanufacturing, and healthcare industry enhancements are a few other key factors fuelling the global single-use bioprocessing market.

The increasing popularity of disposables in biopharmaceutical manufacturing, rising chronic diseases leading to the need for biological treatment, affordable disposable products and instruments, and developing life science research infrastructure drive the global single-use bioprocessing market growth. Moreover, advancements in the technology of bioprocessing systems are also expected to fuel market growth. Growing numbers of joint ventures and acquisitions and quick launches of new products are the significant trends of this global single-use bioprocessing market.

MARKET RESTRAINTS:

However, extractability problems about disposing of plastic bags and possible environmental harm are the factors that are restricting the growth of the single-use bioprocessing market. Moreover, the waste disposal of single-use processes is also a significant challenge the market faces.

Impact of COVID-19 on the single-use bioprocessing market:

COVID-19 is a newly discovered coronavirus that produces a contagious illness. Before the outbreak in Wuhan, China, in December 2019, the COVID-19 virus was largely unknown. However, it has progressed from a localized problem to a global pandemic since then. Following the World Health Organization's (WHO) classification of the virus outbreak as a pandemic, a slew of large pharmaceutical companies and small start-ups have rushed to develop the treatments and vaccinations to battle the rare coronavirus infection.

Many biopharmaceutical companies have been working quickly to produce vaccinations in response to the novel coronavirus pandemic. If these development programs make it through the trial phases, single-use equipment and systems will be used to support the clinical and commercial manufacturing platforms. Because most of the leading COVID-19 vaccine programs rely on cutting-edge technologies like mRNA, DNA vaccines, and vectors, these platforms are often single-use. Single-use systems are more versatile and may be introduced more quickly and at a lower cost than traditional stainless-steel equipment, which requires significant upfront investments and has no assurance of long-term durability.

Many renowned producers of single-use bioprocessing equipment are currently partnering with firms developing or testing a coronavirus vaccine in the race to develop a vaccine.

REPORT COVERAGE:

This research report has been segmented and sub-segmented the global single-use bioprocessing market into the following categories.

Single-use Bioprocessing Market – By Product:

• Media Bags and Containers
• Filtration assemblies
• Single-use Bioreactors
• Disposable Mixers
• Others

Based on the product, the media bags and containers segment is predicted to account for the largest share in the global single-use bioprocessing market during the forecast period due to the growing adoption of media bags and containers in transportation and storage.

Single-use Bioprocessing Market – By Application:

• Filtration
• Storage
• Cell Culture
• Mixing and Purification

Based on the application, the filtration segment is expected to lead the market due to the growing popularity of single-use tangential flow filters, depth filters, and chromatography columns in the process development.

Single-use Bioprocessing Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the single-use bioprocessing market in North America is predicted to lead the global market, followed by Europe during the forecast period. The North American market size was estimated at USD 1 billion in 2020. Extensive biopharmaceutical manufacturing services and the high amount spent on research and development accelerates the North American Market. The United States is expected to top the North American market between 2020 to 2025. The increased expenditure spent on the healthcare sector and biologics spur market development. Furthermore, the continuous product launches and growing popularity of disposables are expected to favor the U.S. market. The Canadian market is next to the U.S. to account for the second-majority market share. Low production price, growing awareness, and increasing incidence of chronic diseases primarily drive the Canadian market.

The single-use bioprocessing market in Europe had accounted for a substantial share in the global market in 2020 and is estimated to showcase a CAGR of 17.6% between 2020 to 2025. Factors such as increasing R&D activities, growing disposable biopharmaceuticals, and immense manufacturing capabilities expand the market growth. The U.K single-use bioprocessing market is presently leading the EU market and is forecasted to play a leading role during the forecast period. The German market is predicted to have a tremendous growth rate due to a surge in biopharmaceutical and biotech companies, intensifying system sales. According to Statista data, the number of committed biotech companies in Germany was 593 in 2015 and has risen to 679in 2018. 

However, The single-use bioprocessing market in Asia-Pacific will grow at the highest CAGR because of ample investment opportunities, especially in China, India, Australia, and New Zealand. The APAC market size is expected to be worth USD 1.89 billion by 2025. Growing government initiatives and the efforts of key market participants to better the healthcare infrastructure is favoring the market in this region. The Chinese market is well-known for exporting biopharmaceutical activities such as chemical drugs. In July 2019, Sartorius opened a tech support center for biotech processing in Zhangjiang, Shanghai, China. The Indian single-use bioprocessing market to have a reasonable growth rate throughout the forecast period. The rising patient count, novel diseases, and accentuating lifestyle changes support the Indian market.

The single-use bioprocessing market in Latin America will have a substantial growth rate during the forecast period. The local manufacturers' focus on expanding their product portfolio and launching new advanced technology products are driving the Latin American market. As a result, Brazil is expected to lead the Latin American market. 

The single-use bioprocessing market in the Middle East and Africa witness a slow growth rate during the forecast period. Factors such as the growing demand for cost-effective bioprocessing systems are expected to drive the market. 

KEY MARKET PARTICIPANTS:

Some of the prominent companies leading single-use bioprocessing market profiled in this report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.

RECENT HAPPENINGS IN THIS MARKET:

• In March 2021, Thermo Fisher Scientific Inc. announced to invest more than 600 million USD in accelerating its bioprocessing production capabilities.
• In March 2020, Danaher Corporation acquired the Biopharma business from the General Electric Life Sciences division.